Androstenone Derivative

Abstract

The present invention relates to the compound of formula (I), <IMAGE> (I) also known as 17 beta -N-(2,5-bis(Trifluoromethyl))phenylcarbamoyl-4-aza-5 alpha -androst-1-en-3-one, solvates thereof, its preparation, intermediates used in its preparation, pharmaceutical formulations thereof and its use in the treatment of androgen responsive and mediated diseases.


Claims
Download PDF
Document Preview
Document History
  • Publication: Oct 15, 1996
  • Application: Mar 16, 1995
    US US 40512095 A
  • Priority: Mar 16, 1995
    US US 40512095 A
  • Priority: Sep 17, 1993
    US US 12328093 A

Download Citation


Sign in to the Lens

Feedback